Chris Smalley has recently joined Merck, where he has responsibility for innovative processes implementation and validation, including Single Use Systems, worldwide in the vaccine, pharmaceutical and biotechnology businesses of the organization.
Previously, he had been Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and conducting validation activities globally in the pharmaceutical, biotechnology, consumer health and nutritional businesses.
His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier he had worked for the Johnson & Johnson family of companies, where he was the Plant Manager for the Parenterals facility for Janssen Pharmaceutica.
Chris retired from the United States Air Force as a LtCol where he practiced as a pharmacist and healthcare administrator, and is a graduate of the Philadelphia College of Pharmacy of the University of the Sciences in Philadelphia.
graduate education includes a MBA from Temple University Fox School of Business and a Masters of Science in Pharmaceutical Chemistry from Temple University School of Pharmacy.
Chris is a member of the PDA Board of Directors, as well as a member of the Science Advisory Board.